Cognitive & Sleep Stack Cognitive & Sleep Stack STACK IMAGE
BATCH COA SUPPLIED HPLC VERIFIED RESEARCH USE ONLY
— STACK · 3 COMPOUNDS

Cognitive & Sleep Stack Semax + Selank + DSIP

For in vitro research use only. Cognitive & Sleep Stack is not for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

Research bundle combining three neuropeptides studied across distinct but related neurological pathways. Semax is investigated for BDNF expression and neuroprotection; Selank for anxiolytic-like profiles and serotonergic modulation; DSIP for its effects on slow-wave sleep architecture and stress-axis signalling.

Research overview

Research bundle combining three neuropeptides studied across distinct but related neurological pathways. Semax is investigated for BDNF expression and neuroprotection; Selank for anxiolytic-like profiles and serotonergic modulation; DSIP for its effects on slow-wave sleep architecture and stress-axis signalling. Together they cover cognitive, stress-response, and sleep regulation pathway research in a single bundle. Three individual lyophilised vials. For in vitro research use only.

Compounds in this stack

Semax

ACTH(4-7) Pro-Gly-Pro Analogue

A synthetic 7-amino-acid peptide based on a section of the stress hormone ACTH, with a stabilising tail added to improve its reach within biological systems. Preclinical studies have measured increased BDNF expression — a protein associated with brain cell growth and survival — in neuronal tissue following administration.

CAS 80714-61-0 99% HPLC View Semax →

Selank

Synthetic Heptapeptide (TKPRPGP)

A synthetic 7-amino-acid peptide based on a fragment of the immune protein tuftsin. Rodent studies have documented calmer behaviour in treated animals without observed sedation — a profile that distinguishes it from classical anxiolytic compounds in research settings.

CAS 129954-34-3 98.9% HPLC View Selank →

DSIP

Delta Sleep-Inducing Peptide

A 9-amino-acid neuropeptide first isolated from rabbit blood during deep sleep states. Animal studies investigate its effects on the architecture of sleep — particularly slow-wave and delta sleep stages — as well as its interaction with the body's stress-response axis.

CAS 62568-57-4 98.7% HPLC View DSIP →

Compliance notice

For in vitro research use only. This stack is supplied solely as research reagents for qualified professionals conducting in vitro or animal-model studies. No compound in this stack is a medicinal product. None has been evaluated by the MHRA or FDA. None is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.

Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.